Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial

IMPORTANCE: Although the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for EGFR gene mutation–positive non–small cell lung cancer is well established, optimal dosing remains to be established, especially in elderly or frail patients. OBJECTIVE: To investigate the efficacy a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA Oncol
Egile Nagusiak: Miyamoto, Shingo, Azuma, Koichi, Ishii, Hidenobu, Bessho, Akihiro, Hosokawa, Shinobu, Fukamatsu, Nobuaki, Kunitoh, Hideo, Ishii, Mari, Tanaka, Hiroshi, Aono, Hiromi, Nakahara, Yoshiro, Kusaka, Kei, Hosomi, Yukio, Kikuchi, Norihiro, Mori, Yoshiaki, Itani, Hidetoshi, Hamada, Akinobu, Yamada, Kazuhiko, Okamoto, Hiroaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Medical Association 2020
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226294/
https://ncbi.nlm.nih.gov/pubmed/32407455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.1250
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak